Fundz

Kenox Pharmaceuticals Appoints Dr. Julianne Berry as Vice President of R&D and Manufacturing

PRIVATEOct 21, 2025

Position

Vice President of Manufacturing

Company

Kenox Pharmaceuticals

Julianne Berry
jberry@kenoxpharma.us
Monmouth JunctionBiotechnologyHealth CareTherapeuticsPharmaceuticalpharmaceuticals

Description

Kenox Pharmaceuticals Inc has announced the appointment of Dr Julianne Berry as Vice President of R&D and Manufacturing. Dr Berry will oversee integrated development, manufacturing, and testing operations to drive innovation and efficiency.

Who to call at Kenox Pharmaceuticals, and when

A new leader at Kenox Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Kenox Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kenox Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kenox Pharmaceuticals. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kenox Pharmaceuticals

Location

11 Deerpark Dr

Monmouth Junction, New Jersey, United States

About

Kenox Pharmaceuticals Inc is a fast-growing company dedicated to developing innovative Orally Inhaled and Nasal Drug Products (OINDPs). Established in 2018, Kenox specializes in pharmaceutical aerosol product development, offering expertise in formulation design, compounding, fill-finish, and testing in compliance with compendial monographs. The company aims to accelerate the journey from molecule to clinic, providing high-quality end-to-end solutions for biopharmaceutical innovators. Kenox is committed to supporting partners in developing cutting-edge therapeutics for unmet medical needs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kenox Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Julianne
Likely contact at this company
••••••••@••••••••

See Julianne's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Kenox Pharmaceuticals's next move

Learn about Strategic plan

Kenox Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.